Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Musculoskeletal | Neurology | Cardiology/Vascular Diseases
Disease Category: Chest Pain
Trial Information
A Study to Evaluate the Benefit of Cardiovascular Risk Stratification in Patients With Chest Pain.
Status: Completed
Protocol Number: 17
Sponsor:
Company Division: Diagnostic
Official Scientific Title: Health-economic benefit of the Point-of-Care clarification of acute coronary syndrome, thromboembolism and cardiac failure in primary health care.
Brief Summary: This study will evaluate the clinical and socioeconomic benefit of laboratory-supported cardiovascular risk stratification in primary health care. The extent of the benefit of point-of-care diagnostics will be analyzed.
Study Phase: N/A
Study Design / Study Details:
- Purpose:
- Allocation: Randomized
- Masking: Open Label
- Control:
- Assignment: Parallel
- Endpoints:
Study Type:
Interventional
Condition: Chest Pain
Intervention Type: Diagnostic Test
Intervention Name: Cardiac-Reader
Primary Outcome:
Key Secondary Outcomes:
Inclusion Criteria:
- adult patients >=18 years of age;
- chest pain;
- dyspnea.
Exclusion Criteria:
- onset of symptoms >=5 days before attending hospital;
- therapeutic doses of heparin for >24 hours;
- severe reanl insufficiency.
Gender: Males or Females
Age Limits: Min: 18 Years
Accepts Healthy Volunteers: No
Anticipated Start Date: June, 2006
Trial Registration Date: 11/23/2006
Date Last Updated: 02/07/2008
Link To Trial Results
E-mail: genentechclinicaltrials@druginfo.com
Research Site:
Located In:
Zurich 8091
Switzerland
Phone: 888-662-6728 (U.S. Only)
View Google Map
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
